Gainers
- Dare Bioscience Inc DARE shares climbed 131.11 percent to close at $2.10 on Monday after the company published positive clinical findings for Tamoxifen for the treatment of vulvar and vaginal atrophy in a medical journal.
- Dermira, Inc. DERM shares gained 82.16 percent to close at $12.61 after the company announced that its Phase 2 study of Lebrikizumab met its primary endpoint.
- PhaseBio Pharmaceuticals, Inc. PHAS gained 64.52 percent to close at $6.23 after the New England Journal of Medicine published the positive Phase 1 results for the company's PB2452.
- Selecta Biosciences, Inc. SELB shares rose 46.54 percent to close at $3.06.
- Gritstone Oncology, Inc. GRTS shares gained 31.43 percent to close at $13.34.
- American Midstream Partners, LP AMID climbed 28.5 percent to close at $5.14 after the company announced that it would be acquired by ArcLight Energy for $5.25 per share.
- Atossa Genetics Inc. ATOS rose 24.47 percent to close at $4.40 after the company reported the receipt of $10 million from exercises of previously outstanding warrants.
- Iconix Brand Group, Inc. ICON gained 23.76 percent to close at $2.45.
- Aclaris Therapeutics, Inc. ACRS gained 19.63 percent to close at $6.78 after the company reported higher-than-expected Q4 sales.
- Rockwell Medical, Inc. RMTI climbed 19 percent to close at $6.21.
- Mesoblast Limited MESO rose 18.49 percent to close at $5.17.
- Sorrento Therapeutics, Inc. SRNE gained 18.03 percent to close at $2.75.
- Liquid Media Group Ltd. YVR gained 17.35 percent to close at $3.45.
- Translate Bio, Inc. TBIO climbed 16.63 percent to close at $9.61. Translate Bio highlighted publication of preclinical data demonstrating efficacy of systemic mRNA delivery in Fabry disease model in the Journal Molecular Therapy.
- Smart Sand, Inc. SND rose 16.42 percent to close at $4.67.
- DASAN Zhone Solutions, Inc. DZSI rose 15.54 percent to close at $11.81. DASAN Zhone expects Q1 organic revenue of $63 million to $66 million and FY19 organic revenue of $304 million to $310 million.
- Viomi Technology Co., Ltd VIOT climbed 15.13 percent to close at $12.00 after reporting Q4 results.
- Innovate Biopharmaceuticals, Inc. INNT shares gained 14.94 percent to close at $2.48 after reporting entry into securities purchase agreement to fund initiation of the first Phase 3 celiac disease clinical trial.
- Village Farms International, Inc. VFF gained 14.01 percent to close at $16.33.
- Replimune Group, Inc. REPL climbed 13.57 percent to close at $13.13.
- Karyopharm Therapeutics Inc. KPTI gained 12.95 percent to close at $5.31.
- Synthorx, Inc. THOR gained 12.23 percent to close at $21.51.
- Akari Therapeutics, Plc AKTX rose 12.01 percent to close at $4.57 after falling 29.66 percent on Friday.
- Cellectar Biosciences, Inc. CLRB climbed 11.97 percent to close at $2.74.
- Overseas Shipholding Group, Inc. OSG shares rose 11.84 percent to close at $2.55.
- Digital Turbine, Inc. APPS shares jumped 11.76 percent to close at $3.39 on Monday.
- AVROBIO, Inc. AVRO gained 11.73 percent to close at $17.63.
- 360 Finance, Inc. QFIN rose 11.64 percent to close at $16.51.
- CHF Solutions, Inc. CHFS gained 11 percent to close at $3.92.
- Triple-S Management Corporation GTS rose 10.85 percent to close at $27.28.
- China SXT Pharmaceuticals, Inc. SXTC rose 10.82 percent to close at $6.96.
- Worldpay, Inc. WP shares gained 9.96 percent to close at $108.51. Fidelity National Information Services Inc FIS agreed to buy Worldpay for around $35 billion.
- Oragenics, Inc. OGEN gained 7.6 percent to close at $0.9576 after the company announced it has enrolled the 60th patient in its Phase 2 double-blind for its clinical trial of AG013.
- Cue Biopharma, Inc. CUE rose 7.12 percent to close at $8.56.
- Avid Technology, Inc. AVID shares rose 5.06 percent to close at $6.53.
- Deutsche Bank AG DB rose 4.3 percent to close at $9.26 after confirming it's in merger talks with fellow German-based bank Commerzbank.
- AzurRx BioPharma, Inc. AZRX shares rose 4.2 percent to close at $2.14 after the company announced it will present Phase II MS1819-SD data at the 2019 Digestive Disease Week Conference.
Losers
- Aerpio Pharmaceuticals Inc ARPO shares tumbled 70.54 percent to close at $1.22 on Monday after the company announced that its Phase 2 TIME-2b study of AKB-9778 did not meet its primary endpoint.
- NII Holdings, Inc. NIHD dropped 27.9 percent to close at $2.27. NII Holdings posted Q4 earnings of $0.02 per share on sales of $141.7 million. The company also announced the sale of Nextel Brazil to America Movil.
- Synaptics Incorporated SYNA shares fell 22.46 percent to close at $33.46 after the company lowered its guidance for the third quarter and reported the departure of CFO Richard Bergman.
- FutureFuel Corp. FF shares fell 20.95 percent to close at $14.11 after the company reported Q4 EPS of $0.04, down from $0.36 last year and Q4 sales of $65.51 million, down from $75.26 million last year.
- Globus Maritime Limited GLBS fell 19.22 percent to close at $4.6100. Globus Maritime reported a Q4 loss of $0.42 per share, on sales of $4.36 million.
- Sensus Healthcare, Inc. SRTS dropped 16.25 percent to close at $7.90.
- BioScrip, Inc. BIOS fell 15.47 percent to close at $2.34. Stephens & Co. downgraded BioScrip from Overweight to Equal-Weight.
- Polarityte Inc PTE fell 15.29 percent to close at $13.05 after the company announced it is the subject of an SEC investigation and used $8M of cash during a 2 month transitional period.
- Trinity Place Holdings Inc. TPHS dipped 14.13 percent to close at $4.0100.
- vTv Therapeutics Inc VTVT fell 13.91 percent to close at $2.0000 after reporting $15 million in Class A common stock financings.
- PHI, Inc. PHII dipped 12.64 percent to close at $2.49. PHI posted Q4 results on Monday.
- GP Strategies Corporation GPX shares dropped 12.63 percent to close at $12.52 after reporting downbeat Q4 results.
- Qutoutiao Inc. QTT dropped 12.6 percent to close at $13.57.
- Adamis Pharmaceuticals Corporation ADMP fell 12.1 percent to close at $2.3900 after dropping 3.90 percent on Friday.
- CohBar, Inc. CWBR dipped 9.74 percent to close at $3.4700.
- Ra Medical Systems, Inc. RMED fell 9.71 percent to close at $4.00.
- KalVista Pharmaceuticals, Inc. KALV dropped 9.67 percent to close at $26.33.
- Adial Pharmaceuticals, Inc. ADIL fell 9.06 percent to close at $3.01.
- Coda Octopus Group, Inc. CODA dropped 7.69 percent to close at $8.55. Coda Octopus reported Q1 earnings of $0.12 per share on sales of $5.76 million.
- Huami Corporation HMI shares fell 6.36 percent to close at $14.44 after gaining 5.91 percent on Friday.
- Turtle Beach Corporation HEAR dipped 6.31 percent to close at $12.46.
- Chaparral Energy, Inc. CHAP shares dropped 6.3 percent to close at $4.4600.
- Key Energy Services, Inc. KEG fell 6.02 percent to close at $5.78.
ADILAdial Pharmaceuticals Inc
$0.7615-0.98%
AKTXAkari Therapeutics PLC
$0.9799-7.12%
AMIDArgent Mid Cap ETF
$35.002.46%
APPSDigital Turbine Inc
$4.21-12.1%
ATOSAtossa Therapeutics Inc
$0.8012-4.61%
CLRBCellectar Biosciences Inc
$0.3065-8.34%
CODACoda Octopus Group Inc
$7.63-3.17%
CUECue Biopharma Inc
$1.380.73%
CWBRCohBar Inc
$0.4100-%
DAREDare Bioscience Inc
$3.10-1.90%
DBDeutsche Bank AG
$20.30-0.44%
DERMJourney Medical Corp
$4.95-3.70%
DZSIDZS Inc
$0.7200-6.49%
FFFutureFuel Corp
$4.73-1.46%
FISFidelity National Information Services Inc
$69.25-0.86%
GLBSGlobus Maritime Ltd
$1.29-4.44%
ICONIcon Energy Corp
$0.2880-14.4%
KALVKalVista Pharmaceuticals Inc
$10.00-6.02%
KPTIKaryopharm Therapeutics Inc
$0.6090-0.16%
MESOMesoblast Ltd
$16.36-5.07%
OGENOragenics Inc
$0.28500.78%
QFINQifu Technology Inc
$41.88-1.27%
REPLReplimune Group Inc
$14.04-1.89%
RMTIRockwell Medical Inc
$1.80-%
SNDSmart Sand Inc
$2.404.35%
SRNESorrento Therapeutics Inc
$0.0006020.0%
SRTSSensus Healthcare Inc
$5.39-3.06%
SXTCChina SXT Pharmaceuticals Inc
$0.3500-6.29%
SYNASynaptics Inc
$71.76-4.94%
TBIOTelesis Bio Inc
$0.400014.3%
TPHSTrinity Place Holdings Inc
$0.0680-2.86%
VFFVillage Farms International Inc
$0.75500.72%
VIOTViomi Technology Co Ltd
$1.58-%
VTVTvTv Therapeutics Inc
$20.60-1.39%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in